| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 27, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and...
-
Nov 13, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Credit Suisse...
-
Nov 13, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote® (acetylcysteine)...
-
Nov 7, 2012- Fiscal first quarter adjusted net income increased 16% to a record $119 million, or $1.27 per diluted share, inclusive of an $0.08 tax benefit.
Perrigo Company (Nasdaq: PRGO; TASE: PRGO) today announced results for its first quarter ended September 29, 2012. (Logo:...
-
Nov 6, 2012
The Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors has appointed Jacqualyn A. Fouse, Ph.D. as a new director of the...
-
Nov 6, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on December...
-
Oct 23, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it will release financial results for its first quarter fiscal year 2013 on Wednesday,...
-
Oct 16, 2012
The Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for...
-
Oct 10, 2012
The Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its...
-
Oct 1, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has closed the acquisition of Sergeant's Pet Care Products, Inc. (Sergeant's), a...
-
Sep 18, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer Judy Brown will present at the...
-
Sep 13, 2012-- Sergeant's Pet Care Products, Inc., a privately-held OTC animal health company, expands Perrigo's portfolio to include a new adjacent product category, companion animal healthcare
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has signed a definitive agreement to acquire substantially all of the assets of...
-
Sep 7, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley Global...
-
Sep 6, 2012
Perrigo Company (Nasdaq: PRGO; TASE) announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration...
-
Aug 27, 2012
Perrigo Company (Nasdaq: PRGO;TASE) and Tris Pharma, Inc. today announced the commercial launch of a major new store brand...
-
Aug 16, 2012- Full-year revenue from continuing operations increased $418 million, or 15%, to a record $3.2 billion.
Perrigo Company (Nasdaq: PRGO; TASE) today announced results for its fourth quarter and full year ended June 30, 2012. (Logo:...
-
Aug 15, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.08 per share, payable on September...
-
Aug 9, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...
-
Aug 8, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...
-
Aug 2, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it will release financial results for its fourth quarter and fiscal year 2012 on Thursday,...
-
Jun 27, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...
-
Jun 11, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Clobetasol propionate...
-
Jun 8, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer Judy Brown will present at the...
-
Jun 6, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...
-
May 30, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that the U.S. Food and Drug Administration has granted final approval to Tris Pharma for its...